Literature DB >> 30310236

Therapeutic strategies targeting connexins.

Dale W Laird1, Paul D Lampe2.   

Abstract

The connexin family of channel-forming proteins is present in every tissue type in the human anatomy. Connexins are best known for forming clustered intercellular channels, structurally known as gap junctions, where they serve to exchange members of the metabolome between adjacent cells. In their single-membrane hemichannel form, connexins can act as conduits for the passage of small molecules in autocrine and paracrine signalling. Here, we review the roles of connexins in health and disease, focusing on the potential of connexins as therapeutic targets in acquired and inherited diseases as well as wound repair, while highlighting the associated clinical challenges.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30310236      PMCID: PMC6461534          DOI: 10.1038/nrd.2018.138

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  298 in total

1.  Connexin43 modulation inhibits scarring in a rabbit eye glaucoma trabeculectomy model.

Authors:  Narmadai C Deva; Jie Zhang; Colin R Green; Helen V Danesh-Meyer
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology.

Authors:  Elisabeth Obert; Randy Strauss; Carlene Brandon; Christina Grek; Gautam Ghatnekar; Robert Gourdie; Bärbel Rohrer
Journal:  J Mol Med (Berl)       Date:  2017-01-28       Impact factor: 4.599

3.  Pannexin 1 Channels as an Unexpected New Target of the Anti-Hypertensive Drug Spironolactone.

Authors:  Miranda E Good; Yu-Hsin Chiu; Ivan K H Poon; Christopher B Medina; Joshua T Butcher; Suresh K Mendu; Leon J DeLalio; Alexander W Lohman; Norbert Leitinger; Eugene Barrett; Ulrike M Lorenz; Bimal N Desai; Iris Z Jaffe; Douglas A Bayliss; Brant E Isakson; Kodi S Ravichandran
Journal:  Circ Res       Date:  2017-12-13       Impact factor: 17.367

4.  Cell-to-cell passage of large molecules.

Authors:  Y Kanno; W R Loewenstein
Journal:  Nature       Date:  1966-11-05       Impact factor: 49.962

5.  Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.

Authors:  Christina L Grek; G M Prasad; Vijay Viswanathan; David G Armstrong; Robert G Gourdie; Gautam S Ghatnekar
Journal:  Wound Repair Regen       Date:  2015-04-29       Impact factor: 3.617

6.  Connexin expression patterns in human trophoblast cells during placental development.

Authors:  E Winterhager; C Von Ostau; M Gerke; R Gruemmer; O Traub; P Kaufmann
Journal:  Placenta       Date:  1999-11       Impact factor: 3.481

7.  Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo.

Authors:  V A Krutovskikh; S M Troyanovsky; C Piccoli; H Tsuda; M Asamoto; H Yamasaki
Journal:  Oncogene       Date:  2000-01-27       Impact factor: 9.867

Review 8.  Differentiating connexin hemichannels and pannexin channels in cellular ATP release.

Authors:  Alexander W Lohman; Brant E Isakson
Journal:  FEBS Lett       Date:  2014-02-15       Impact factor: 4.124

9.  Cardiac malformation in neonatal mice lacking connexin43.

Authors:  A G Reaume; P A de Sousa; S Kulkarni; B L Langille; D Zhu; T C Davies; S C Juneja; G M Kidder; J Rossant
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

Review 10.  Closing the gap on autosomal dominant connexin-26 and connexin-43 mutants linked to human disease.

Authors:  Dale W Laird
Journal:  J Biol Chem       Date:  2007-12-18       Impact factor: 5.157

View more
  57 in total

1.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice.

Authors:  Yuanyuan Kuang; Veronica Zorzi; Damiano Buratto; Gaia Ziraldo; Flavia Mazzarda; Chiara Peres; Chiara Nardin; Anna Maria Salvatore; Francesco Chiani; Ferdinando Scavizzi; Marcello Raspa; Min Qiang; Youjun Chu; Xiaojie Shi; Yu Li; Lili Liu; Yaru Shi; Francesco Zonta; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  EBioMedicine       Date:  2020-06-15       Impact factor: 8.143

2.  Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repair.

Authors:  Kristin J Lastwika; Clarence A Dunn; Joell L Solan; Paul D Lampe
Journal:  J Cell Sci       Date:  2019-09-23       Impact factor: 5.285

3.  Attenuating loss of cardiac conduction during no-flow ischemia through changes in perfusate sodium and calcium.

Authors:  Gregory S Hoeker; Carissa C James; Allison N Tegge; Robert G Gourdie; James W Smyth; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-17       Impact factor: 4.733

4.  Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy.

Authors:  Eric Himelman; Mauricio A Lillo; Julie Nouet; J Patrick Gonzalez; Qingshi Zhao; Lai-Hua Xie; Hong Li; Tong Liu; Xander Ht Wehrens; Paul D Lampe; Glenn I Fishman; Natalia Shirokova; Jorge E Contreras; Diego Fraidenraich
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

5.  Modulating cardiac conduction during metabolic ischemia with perfusate sodium and calcium in guinea pig hearts.

Authors:  Sharon A George; Gregory Hoeker; Patrick J Calhoun; Michael Entz; Tristan B Raisch; D Ryan King; Momina Khan; Chandra Baker; Robert G Gourdie; James W Smyth; Morten S Nielsen; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

6.  Cellular signaling crosstalk between Wnt signaling and gap junctions inbenzo[a]pyrene toxicity.

Authors:  Dong-Hoon Won; Da-Bin Hwang; Yoo-Sub Shin; Shin-Young Kim; Changuk Kim; In-Sun Hong; Byeong-Cheol Kang; Jeong-Hwan Che; Jun-Won Yun
Journal:  Cell Biol Toxicol       Date:  2021-07-20       Impact factor: 6.691

Review 7.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

8.  S-nitrosylation of connexin43 hemichannels elicits cardiac stress-induced arrhythmias in Duchenne muscular dystrophy mice.

Authors:  Mauricio A Lillo; Eric Himelman; Natalia Shirokova; Lai-Hua Xie; Diego Fraidenraich; Jorge E Contreras
Journal:  JCI Insight       Date:  2019-12-19

Review 9.  Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Authors:  Michelle L Hastings; John V Brigande
Journal:  Hear Res       Date:  2020-03-05       Impact factor: 3.208

Review 10.  Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.

Authors:  Xun Ai; Jiajie Yan; Steven M Pogwizd
Journal:  Cell Signal       Date:  2021-07-02       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.